Editas Medicine to Restructure, Cut 20% of Staff MarketWatch Nawigacja wpisu Foundation Medicine and Natera Announce the Launch of FoundationOne®Tracker Personalized Circulating Tumor DNA Monitoring Assay for Investigational Use and Early Access Clinical Use – Yahoo Finance Editas Medicine Announces Strategic Updates and Portfolio Reprioritization – Yahoo Finance